Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients

Published:2009-02 Issue:2 Volume:111 Page:165-170
ISSN:0303-8467
Container-title:Clinical Neurology and Neurosurgery
language:en
Short-container-title:Clinical Neurology and Neurosurgery

Author:

Brouns Raf,Heylen Evelien,Sheorajpanday Rishi,Willemse Johan L.,Kunnen Jan,De Surgeloose Didier,Hendriks Dirk F.,De Deyn Peter P.

Publisher

Elsevier BV

Subject

Clinical Neurology,General Medicine,Surgery

Reference19 articles.

1. Established treatments for acute ischaemic stroke;Khaja;Lancet,2007

2. Experimental treatments for acute ischaemic stroke;Sacco;Lancet,2007

3. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin–thrombomodulin complex;Bajzar;J Biol Chem,1996

4. Characterisation of a carboxypeptidase in human serum distinct from carboxypeptidase N;Hendriks;J Clin Chem Clin Biochem,1989

5. A role for procarboxypepidase U (TAFI) in thrombosis;Willemse;Front Biosci,2007

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carboxypeptidase U (TAFIa) Is Rapidly Activated and Deactivated Following Thrombolysis and Thrombectomy in Stroke Patients;Translational Stroke Research;2021-11-19

2. Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?;International Journal of Molecular Sciences;2021-01-17

3. Selective inhibition of carboxypeptidase U may reduce microvascular thrombosis in rat experimental stroke;Journal of Thrombosis and Haemostasis;2020-10

4. Blood Biomarkers of Parenchymal Damage in Ischemic Stroke Patients Treated With Revascularization Therapies;Biomarker Insights;2019-01

5. Procarboxypeptidase U (proCPU, TAFI, proCPB2) in cerebrospinal fluid during ischemic stroke is associated with stroke progression, outcome and blood-brain barrier dysfunction;Journal of Thrombosis and Haemostasis;2017-12-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3